JP MORGAN/CALL/BOSTON SCIENTIFIC/75/0.1/15.11.24 | Real-time Bid/Ask 01:06:51 2024-07-17 pm EDT | ||
| 0.8 EUR / 0.81 EUR | -3.01% |
|
| Current month | +1.22% | ||
| 1 month | +1.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 0.82 | -1.20% |
| 24-07-16 | 0.83 | +3.75% |
| 24-07-15 | 0.8 | +1.27% |
| 24-07-12 | 0.79 | 0.00% |
| 24-07-11 | 0.79 | +5.33% |
Delayed Quote Börse Stuttgart
Last update July 17, 2024 at 07:33 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK4K6L |
| ISIN | DE000JK4K6L2 |
| Date issued | 2024-03-19 |
| Strike | 75 $ |
| Maturity | 2024-11-15 (121 Days) |
| Parity | 10 : 1 |
| Emission price | 0.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.91 € |
|---|---|
| Lowest since issue | 0.5 € |
| Spread | 0.01 € |
| Spread % | 1.23% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
78.14
USD
Average target price
84.1
USD
Spread / Average Target
+7.63%
- Stock Market
- Warrants
- Warrant
